| Drug insight: Statin use in the elderly. | |
| | |
MedLine Citation:
|
PMID: 16729010 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The elderly represent a notable proportion of patients who present with myocardial infarction or acute coronary syndromes. This subgroup of patients also experiences a higher incidence of adverse outcomes than younger age-groups, and, therefore, has more to gain from effective, evidence-based therapies. The efficacy of statins in secondary cardiovascular disease prevention is firmly established. The starting of therapy soon after an acute coronary event has been shown to provide added benefit. Uncertainties about the effectiveness of statins in the elderly, however, have resulted in their underuse in this population. In this review we evaluate the evidence for statin use in this important and increasingly large group of patients. |
| | |
Authors:
|
O Christopher Raffel; Harvey D White |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Nature clinical practice. Cardiovascular medicine Volume: 3 ISSN: 1743-4297 ISO Abbreviation: - Publication Date: 2006 Jun |
Date Detail:
|
Created Date: 2006-05-26 Completed Date: 2006-08-18 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 101226507 Medline TA: Nat Clin Pract Cardiovasc Med Country: England |
Other Details:
|
Languages: eng Pagination: 318-28 Citation Subset: IM |
Affiliation:
|
Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Cholesterol, LDL / blood Coronary Disease / blood, drug therapy*, economics, prevention & control Cost-Benefit Analysis Drug Utilization Health Services for the Aged / economics* Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects, economics, therapeutic use* Meta-Analysis as Topic Middle Aged Myocardial Infarction / blood, drug therapy*, economics, prevention & control Patient Compliance Physician's Practice Patterns* Practice Guidelines as Topic Randomized Controlled Trials as Topic Recurrence / prevention & control Risk Assessment |
| Chemical | |
Reg. No./Substance:
|
0/Cholesterol, LDL; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Infective endocarditis: diagnosis and management.
Next Document: Technology insight: Clinical role of magnetic resonance angiography in the diagnosis and management ...